Ontario Public Health Emergencies Science Advisory Committee (OPHESAC) Conflict of Interest Summary

The following is a list of members of the OPHESAC along with their respective conflict of interest declarations. These declarations are provided to ensure transparency and accountability in the advisory process. Each member has disclosed any potential or actual conflicts of interest to maintain the integrity of the committee's work and ensure that recommendations are made in the best interest of public health.

Committee Member

Disclosures

Dr. Upton Allen
Chair

No disclosures

Dr. Na-Koshie Lamptey
Vice-Chair

No disclosures

Amanda Mongeon

No disclosures

Dr. Christopher Mushquash

No disclosures

Dr. Aaron Orkin

Canadian Red Cross – Research and evaluation grants and Scientific Advisory Committee membership.

Dr. Stephanie Premji

No disclosures

Dr. Lynda Redwood-Campbell

No disclosures

Dr. Gilla Shapiro

EBT3 Psychology – Receiving compensation as a psychologist  at a private clinic.

Dr. Marek Smieja

No disclosures

Dr. Maxwell J. Smith

No disclosures

Dr. Kednapa Thavorn

No disclosures

Dr. J. Scott Weese

Antech Diagnostics, Global Antimicrobial Research and Development Partnership (GARDP), Hills Pet Nutrition, Mars Veterinary Health, Merck Animal Health, Royal Canin Canada, VetMedux, Vetoquinol, Zoetis – Speaker fees for non-commercial presentations, Editor-in-chief, antimicrobial assessment.

Mitigation strategy: Mitigation strategies are in place to manage each conflict individually on a case-by-case basis.

Note: This summary is intended to provide transparency regarding potential conflicts of interest for members of the OPHESAC. The full declarations are kept on record for internal review and reference.

Chat icon

Contact

Communications

communications@oahpp.ca

Published 15 April 2025